Invisible wounds: Suturing the gap between the neurobiology, conventional and emerging therapies for posttraumatic stress disorder.
European Neuropsychopharmacology August 2022 Xénia Gonda, Péter Döme, Berta Erdelyi-Hamza et al.
A sharp increase in the prevalence of neuropsychiatric disorders, including major depression, anxiety, substance use disorders and posttraumatic stress disorder (PTSD) has occurred due to the traumatic nature of the persisting COVID-19 global pandemic. PTSD is estimated to occur in up to 25% of individuals following exposure to acute or chronic trauma, and the pandemic has inflicted both forms...
DOI: 10.1016/j.euroneuro.2022.05.010 (opens in new tab)
Full text (opens in new tab)
PTSD
Neurobiology
Pharmacotherapy
Psychedelics
+2